연구성과로 돌아가기
2020 연구성과별 연구자 정보 (1774 / 2428)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study | Hwang, Yang Ha | Hwang, YH | 8 | Kyungpook Natl Univ, Dept Neurol, Sch Med & Hosp, Daegu, South Korea | F-3068-2013 | HWANG, Yang-Ha | 0000-0002-6665-7481 | HWANG, Yang-Ha | jongskim@amc.seoul.kr; | |
| Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study | Lee, Eun-Jae | Lee, EJ | 9 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul 05505, South Korea | jongskim@amc.seoul.kr; | |||||
| Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study | Kim, Won-Ki | Kim, WK | 10 | Korea Univ, Dept Neurosci, Coll Med, Seoul, South Korea | jongskim@amc.seoul.kr; | |||||
| Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study | Ju, Chung | Ju, C | 11 | Res Headquarters, Shin Poong Pharmaceut, Ansan, South Korea | jongskim@amc.seoul.kr; | |||||
| Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study | Kim, Byung Su | Kim, BS | 12 | Res Headquarters, Shin Poong Pharmaceut, Ansan, South Korea | jongskim@amc.seoul.kr; | |||||
| Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study | Ryu, Jei-Man | Ryu, JM | 13 | Res Headquarters, Shin Poong Pharmaceut, Ansan, South Korea | jongskim@amc.seoul.kr; | |||||
| Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease | Park, Sang Hyoung | Park, SH | 1 | Univ Ulsan, Asan Med Ctr, Dept Gastroenterol, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea | AAG-4341-2021 | Kwak, Sang Gyu | jassa@ewha.ac.kr;sky@amc.seoul.kr; | |||
| Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease | Kim, Hyo Jong | Kim, HJ | 2 | Kyung Hee Univ, Ctr Crohns & Colitis, Dept Gastroenterol, Coll Med, Seoul, South Korea | jassa@ewha.ac.kr;sky@amc.seoul.kr; | |||||
| Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease | Lee, Chang Kyun | Lee, CK | 3 | Kyung Hee Univ, Ctr Crohns & Colitis, Dept Gastroenterol, Coll Med, Seoul, South Korea | AAI-1012-2020 | Lee, Chang | jassa@ewha.ac.kr;sky@amc.seoul.kr; | |||
| Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease | Song, Eun Mi | Song, EM | 4 | Ewha Womans Univ, Dept Internal Med, Sch Med, 260 Gonghangdae Ro, Seoul 07804, South Korea | jassa@ewha.ac.kr;sky@amc.seoul.kr; | |||||
| Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease | Kang, Sang-Bum | Kang, SB | 5 | Catholic Univ Korea, Coll Med, Dept Internal Med, Div Gastroenterol,Daejeon St Marys Hosp, Daejeon, South Korea | 0000-0002-1946-7896 | Kang, Sang-Bum | jassa@ewha.ac.kr;sky@amc.seoul.kr; | |||
| Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease | Jang, Byung Ik | Jang, BI | 6 | Yeungnam Univ, Dept Internal Med, Coll Med, Daegu, South Korea | jassa@ewha.ac.kr;sky@amc.seoul.kr; | |||||
| Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease | Kim, Eun Soo | Kim, ES | 7 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea | jassa@ewha.ac.kr;sky@amc.seoul.kr; | |||||
| Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease | Kim, Kyeong Ok | Kim, KO | 8 | Yeungnam Univ, Dept Internal Med, Coll Med, Daegu, South Korea | jassa@ewha.ac.kr;sky@amc.seoul.kr; | |||||
| Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease | Lee, Yoo Jin | Lee, YJ | 9 | Keimyung Univ, Dept Internal Med, Sch Med, Daegu, South Korea | AAB-9799-2022 | Lee, Yoojin | 0000-0003-1799-0146 | Lee, Yoo Jin | jassa@ewha.ac.kr;sky@amc.seoul.kr; |
페이지 이동: